Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease

Clinical trial NCT06578507 · RECRUITING

Trial details

NCT number: NCT06578507
Sponsor: Theravia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2025-01-21
Primary completion: 2027-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.